![Susana Banerjee: Honoured to co-chair joint ESC/ESMO session at ESCCongress2024](https://oncodaily.com/pub/uploads/2024/09/GWVpHtHW8AAUxOq.png)
Susana Banerjee: Honoured to co-chair joint ESC/ESMO session at ESCCongress2024
Evandro de Azambuja shared a post by Susana Banerjee, on X, adding:
“Excellent European Society of Cardiology-ESC and ESMO session on cardio-oncology.”
Quoting Susana Banerjee‘s post:
“Honoured to co-chair joint ESC/ESMO session at ESCCongress2024– managing cancer treatment-related cardiac toxicities. Acute/long term and late onset side effects- more research needed for cancer survivors.”
Source: Evandro de Azambuja/X and Susana Banerjee/X
Evandro de Azambuja is the Director of Membership for the European Society for Medical Oncology (ESMO) for the 2023-2024 term and the President of the Belgian Society of Medical Oncology (BSMO) from 2023 to 2026. He leads the Medical Support Team at the Jules Bordet Institute, previously known as the BREAST Data Centre. He has an extensive background in clinical research, particularly in breast cancer and clinical trials.
Susana Banerjee is a Professor of Women’s Cancers at The Institute of Cancer Research and a Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust. Her research focuses on personalizing patient treatment, targeted therapies (including PARP inhibitors), and rare gynecological cancers.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023